Search results
Results From The WOW.Com Content Network
Also on January 19, the U.S. passed 400,000 COVID-19 deaths. January 21. The National Strategy for the COVID-19 Response and Pandemic Preparedness is released. January 22. On January 22, the U.S. passed 25 million cases, with one of every 13 Americans testing positive for COVID-19. January 24
This brought the total confirmed U.S. deaths due to coronavirus to 22: 19 in Washington, 1 in California, and 2 in Florida. Hawaii: Second case is reported by Governor David Ige and State health officials is an elderly man who tested positive after returning from travel to Washington state earlier in the month.
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
File:COVID-19 Vaccination Record Card CDC (8-17-2020).pdf. Size of this JPG preview of this PDF file: 710 × 599 pixels. Other resolutions: 284 × 240 pixels | 569 × 480 pixels | 725 × 612 pixels. Original file (725 × 612 pixels, file size: 52 KB, MIME type: application/pdf, 2 pages) This is a file from the Wikimedia Commons.
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
In December 2020, Bahrain approved the vaccine. On 7 May 2021, the World Health Organization added the vaccine to the list of vaccines authorized for emergency use for COVID-19 Vaccines Global Access (COVAX). In May 2021, Zambia approved use of the vaccine. In June 2021, Philippines approved the BIBP vaccine for emergency use.
The President of Israel, Reuven Rivlin, with the first vaccinator in Phase B of the vaccine, at the Israel Institute for Biological Research, BriLife at the Barzilai Medical Center. Israel's COVID-19 vaccination programme, officially named "Give a Shoulder" (Hebrew: לתת כתף), began on 19 December 2020, and has been praised for its speed ...